Odyssey Acquisition is a Special Purpose Acquisition Company (SPAC) to be listed on Euronext Amsterdam, seeking to support and accelerate the development of European businesses primarily in the TMT or Healthcare sectors.

Odyssey Acquisition combines the financial experience of brothers Michael Zaoui and Yoel Zaoui with the managerial experience of Jean Raby and the industry expertise of Dr. Olivier Brandicourt and Michel Combes. 

Odyssey Acquisition is supported by the independent financial advisory firm Zaoui & Co and is complemented by a highly experienced group of Independent Non-Executive Directors comprising Walid Chammah, Andrew Gundlach and Cynthia Tobiano.

In selecting its partner, Odyssey Acquisition will focus on businesses benefiting from strong structural tailwinds, with a differentiated and sustainable operating model, strong financial prospects and ESG credentials, a proven management team and that could benefit from access to the European public capital markets in order to accelerate growth.